The effects of interleukin-7 on the lymphangiogenic properties of human endothelial cells.

Lymphangiogenesis (growth of new lymphatic vessels) is thought to play an important role in cancer lymphatic spread to the regional lymph nodes. However, the molecular pathways involved in lymphangiogenesis and their regulation are still unclear. Recently, there has been a significant advance in the studies of the lymphatic system and lymphangiogenesis as several novel specific lymphatic markers are discovered. Here, the effects of several cytokines on the lymphatic expression of human endothelial cells were studied. Amongst these cytokines, interleukin-7 (IL-7) was found to have significant impact on the lymphatic expression as it induced the expression of podoplanin, prox-1 and LYVE-1 in endothelial cells. Furthermore, IL-7 enhanced endothelial cell growth, migration and generation of lymphatic tubules in vitro via upregulating the expression of the lymphangiogenic growth factor and vascular endothelial growth factor-D. The specificity of these effects of IL-7 was confirmed using blocking anti-bodies and ribozyme transgene technology. These effects of IL-7 were totally abolished when IL-7R null endothelial cell mutants were used. IL-7 activated its transmembrane receptor, IL-7R, on endothelial cells, as well as its downstream signalling intermediates, Jak-1, Jak-3, PI3-K and Stat-5. Selective inhibition of these intermediates using specific inhibitors showed that IL-7 induced the afore-mentioned effects via a Wortmannin sensitive pathway. Collectively, these results demonstrate, for the first time, that IL-7 is a lymphangiogenic growth factor by inducing the lymphangiogenic properties of endothelial cells. This might have a significant impact on the lymphatic spread of solid tumours. Furthermore, interruption of IL-7 signalling might provide an attractive therapeutic option in cancer lymphatic metastasis.

[1]  G. Watkins,et al.  Aberrant expression of interleukin-7 (IL-7) and its signalling complex in human breast cancer. , 2004, European journal of cancer.

[2]  W. Jiang,et al.  Interleukin 7 induces the growth of breast cancer cells through a wortmannin‐sensitive pathway , 2004, The British journal of surgery.

[3]  R. Mansel,et al.  Expression of peroxisome‐proliferator activated receptor‐gamma (PPARγ) and the PPARγ co‐activator, PGC‐1, in human breast cancer correlates with clinical outcomes , 2003 .

[4]  R. Mansel,et al.  Biphasic effects of 17‐β‐estradiol on expression of occludin and transendothelial resistance and paracellular permeability in human vascular endothelial cells , 2003, Journal of cellular physiology.

[5]  H. Kalthoff,et al.  Wortmannin inhibits growth of human non-small-cell lung cancer in vitro and in vivo , 2002, Langenbeck's Archives of Surgery.

[6]  P. Hewett,et al.  Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. , 2002, Cancer research.

[7]  W. Jiang,et al.  Lymphangiogenesis quantification using quantitative PCR and breast cancer as a model. , 2001, Biochemical and biophysical research communications.

[8]  R. Dummer,et al.  Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells. , 2001, Blood.

[9]  G. R. Davies,et al.  Interleukins 7 and 12 are expressed in head and neck squamous cancer. , 2001, Clinical otolaryngology and allied sciences.

[10]  M. Karkkainen,et al.  Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. , 2001, Cancer research.

[11]  M. Pepper,et al.  Lymphangiogenesis and tumor metastasis: myth or reality? , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  L. Orci,et al.  Vascular endothelial growth factor‐C‐mediated lymphangiogenesis promotes tumour metastasis , 2001, The EMBO journal.

[13]  Seppo Ylä-Herttuala,et al.  Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3 , 2001, Nature Medicine.

[14]  Thomas Hawighorst,et al.  Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis , 2001, Nature Medicine.

[15]  Steven A. Stacker,et al.  VEGF-D promotes the metastatic spread of tumor cells via the lymphatics , 2001, Nature Medicine.

[16]  K. Aozasa,et al.  Expression of Interleukin-7 and Its Receptor in Thyroid Lymphoma , 2000, Laboratory Investigation.

[17]  Y. Maehara,et al.  Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues , 2000, British Journal of Cancer.

[18]  K. Moelling,et al.  Phosphorylation and regulation of Raf by Akt (protein kinase B). , 1999, Science.

[19]  K. Matsumoto,et al.  Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  G. Oliver,et al.  Prox1 Function Is Required for the Development of the Murine Lymphatic System , 1999, Cell.

[21]  J. Kurebayashi,et al.  Expression of Vascular Endothelial Growth Factor (VEGF) Family Members in Breast Cancer , 1999, Japanese journal of cancer research : Gann.

[22]  D. Whitcombe,et al.  Detection of PCR products using self-probing amplicons and fluorescence , 1999, Nature Biotechnology.

[23]  Takuma Sasaki,et al.  Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  D. Jackson,et al.  LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan , 1999, The Journal of cell biology.

[25]  E. Tschachler,et al.  Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. , 1999, The American journal of pathology.

[26]  M. Mildner,et al.  Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[27]  K. Alitalo,et al.  Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response , 1999, Oncogene.

[28]  B. Seliger,et al.  Constitutive and IFN-gamma regulated expression of IL-7 and IL-15 in human renal cell cancer. , 1999, International journal of oncology.

[29]  Vishva Dixit,et al.  Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway , 1998, The Journal of Biological Chemistry.

[30]  Yue,et al.  Epithelial component of lymphoid stroma‐rich Warthin's tumour expresses interleukin (IL)‐7 , 1998, Histopathology.

[31]  H. Kiyono,et al.  Bacterial invasion induces interleukin‐7 receptor expression in colonic epithelial cell line, T84 , 1997, European journal of immunology.

[32]  L. Zitvogel,et al.  Interleukin‐7 (IL‐7) in Colorectal Cancer: IL‐7 is Produced by Tissues from Colorectal Cancer and Promotes Preferential Expansion of Tumour Infiltrating Lymphocytes , 1997, Scandinavian journal of immunology.

[33]  L. Aiello,et al.  Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. , 1996, The Journal of clinical investigation.

[34]  C. Soria,et al.  Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro , 1996, International journal of cancer.

[35]  S. Dubinett,et al.  Interleukin-8 inhibits non-small cell lung cancer proliferation: a possible role for regulation of tumor growth by autocrine and paracrine pathways. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[36]  N. Iizuka,et al.  Cytokine mRNA expression patterns in human esophageal cancer cell lines. , 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[37]  I. Kerr,et al.  Interleukin‐7 can induce the activation of Jak 1, Jak 3 and STAT 5 proteins in murine T cells , 1995, European journal of immunology.

[38]  H. Ishii,et al.  Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes. , 1995, The Journal of clinical investigation.

[39]  C. Watson,et al.  Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. , 1995, British Journal of Cancer.

[40]  H. Stein,et al.  Frequent expression of IL-7 gene transcripts in tumor cells of classical Hodgkin's disease. , 1995, The American journal of pathology.

[41]  H. Dadi,et al.  Activation of phosphatidylinositol-3 kinase by ligation of the interleukin-7 receptor is dependent on protein tyrosine kinase activity. , 1994, Blood.

[42]  T. Knobloch,et al.  B cell IL-7. Human B cell lines constitutively secrete IL-7 and express IL-7 receptors. , 1994, Journal of immunology.

[43]  R. Whyte,et al.  Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma , 1994, The Journal of experimental medicine.

[44]  V. Diehl,et al.  Interleukin-7, interleukin-8, soluble TNF receptor, and p53 protein levels are elevated in the serum of patients with Hodgkin's disease. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[45]  P. Gruss,et al.  Prox 1, a prospero-related homeobox gene expressed during mouse development , 1993, Mechanisms of Development.

[46]  J. Frishman,et al.  Genes for Interleukin 7 Are Transcribed in Leukemic Cell Subsets of Hdividuak with Chronic Lymphocytic Leukemia , 1993 .

[47]  P. Leder,et al.  Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice , 1993, The Journal of experimental medicine.

[48]  R. Strieter,et al.  Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.

[49]  D. Kreutzer,et al.  Cytokine expression by head and neck squamous cell carcinomas. , 1992, American journal of surgery.

[50]  R. Strieter,et al.  Interleukin-8. A corneal factor that induces neovascularization. , 1992, The American journal of pathology.

[51]  P. Debré,et al.  Interleukin-7 is a growth factor for Sézary lymphoma cells. , 1992, The Journal of clinical investigation.

[52]  A. Ganser,et al.  In vitro culture of common acute lymphoblastic leukemia blasts: effects of interleukin-3, interleukin-7, and accessory cells. , 1992, Blood.

[53]  H. Imura,et al.  Co‐production of Interleukin‐1 and Interleukin‐6 in Tumor Cell Lines Elaborating Colony‐stimulating Factors , 1991, Japanese journal of cancer research : Gann.

[54]  W. Digel,et al.  Human interleukin-7 induces proliferation of neoplastic cells from chronic lymphocytic leukemia and acute leukemias. , 1991, Blood.

[55]  T. Agthoven,et al.  Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia. , 1990, Blood.

[56]  Masahiro Yamamoto,et al.  Interleukin‐6 (IL‐6) functions as an in vitro autocrine growth factor in renal cell carcinomas , 1989, FEBS letters.